Radiosurgical neuromodulation close to critical structures
Methods of treatment and treatment systems for performing radiomodulatory stereotactic radiosurgery to treat brain disorders in which target neural tissues associated with the brain disorder are sensitized to radiation by administration of a molecular substance and/or non-targeted critical structures are protected from radiation by a molecular substance, in order to treat disorders of brain circuitry. Specific embodiments disclose means for treating pain, obesity and drug addiction.
1. A method of treating a disorder of a brain of a patient, the method comprising:
identifying a non-targeted critical structure physically close to a target tissue of a neural circuit of the brain;
identifying a spatial position of the critical structure within said neural circuit;
selecting, aiming and delivering a non-invasive anatomic-specific blood-brain barrier permeator to a blood brain barrier of the brain;
delivering one or more molecular substances with anatomically specific uptake at the critical structure across the permeated blood-brain barrier, wherein the one or more molecular substances inhibit irradiation of the critical structure; and
transmitting a cellularly sub-lethal quantity of ionizing radiation from outside the patient to the neural circuit, in a manner that the ionizing radiation delivers a therapeutic dose of radiation to the neural circuit while inhibiting damage to the critical structure,
wherein the one or more molecular substances further comprise a substance with anatomic specific uptake at the target tissue of the neural circuit,
wherein the substance has an affinity for a specific brain cell type.
2. The method of claim 1 , wherein the transmitting the ionizing radiation comprises transmitting the ionizing radiation from a radiation source machine positioned outside the patient, through a skull of the patient and into the brain of the patient along a plurality of beam paths directed from varying directions in a manner as to intersect with the critical structure.
3. The method of claim 1 , wherein the one or more molecular substances have an affinity for the specific brain cell type.
4. The method of claim 1 , wherein the substance further comprising a radiosensitizer to facilitate radiation at the target tissue of the neural circuit.
5. The method of claim 1 , wherein said permeator is focused ultrasound.
6. The method of claim 1 , wherein the neural circuit comprises dopamine production neurons in a nucleus accumbens, and wherein transmitting the ionizing radiation comprises transmitting the ionizing radiation into a striatum of the patient which alter an amount of dopamine activity in the nucleus accumbens in a manner that symptoms of drug addiction are mitigated.
7. The method of claim 1 , wherein the delivering one or more molecular substances comprises delivering a radioprotectant to non-dopaminergic neurons within a nucleus accumbens.
8. The method of claim 1 , wherein the one or more molecular substances have cell-type specificity with an affinity for certain types of brain cells.
9. The method of claim 8 , wherein the certain types of brain cells comprise brain neurons and the one or more molecular substances has a specific affinity for any of the following types of brain neurons: Glutamate (GLU) neurons; Gamma-aminobutyric acid (GABA) neurons; and Dopaminergic (DA) neurons.
10. The method of claim 1 , wherein the critical structure is a hippocampus.
11. The method of claim 1 , wherein the critical structure is an amygdala.
12. The method of claim 1 , wherein the critical structure is an optic tract.